Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular disease

被引：14

作者：

Blum, Shany ^{[1
]}

Milman, Uzi ^{[2
,3
,4
]}

Shapira, Clien ^{[4
,5
]}

Levy, Andrew P. ^{[1
]}

机构：

[1] Technion Israel Inst Technol, Dept Anat & Cell Biol, Bruce Rappaport Fac Med, Haifa, Israel

[2] Technion Israel Inst Technol, Dept Family Med, Bruce Rappaport Fac Med, Haifa, Israel

[3] Clalit Hlth Serv, Clin Res Unit, Haifa, Israel

[4] Western Galilee, Haifa, Israel

[5] Lady Davis Carmel Med Ctr, Haifa, Israel

来源：

PHARMACOGENOMICS | 2008年 / 9卷 / 08期

关键词：

D O I：

10.2217/14622416.9.8.989

中图分类号：

R9 [药学];

学科分类号：

1007 [药学];

摘要：

引用

页码：989 / 991

页数：3

共 16 条

[1]

*AM DIAB ASS, 2008, DIABETES CARE, V31, P1, DOI DOI 10.2337/DC07-2052

[2]

Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease [J].

Asleh, R ;

Marsh, S ;

Shilkrut, M ;

Binah, O ;

Guetta, J ;

Lejbkowicz, F ;

Enav, B ;

Shehadeh, N ;

Kanter, Y ;

Lache, O ;

Cohen, O ;

Levy, NS ;

Levy, AP .

CIRCULATION RESEARCH, 2003, 92 (11) :1193-1200

[3]

ASLEH R, 2008, DIABETES

[4]

Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL [J].

Bamm, VV ;

Tsemakhovich, VA ;

Shaklai, M ;

Shaklai, N .

BIOCHEMISTRY, 2004, 43 (13) :3899-3906

[5]

Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotype [J].

Blum, Shany ;

Milman, Uzi ;

Shapira, Chen ;

Miller-Lotan, Rachel ;

Bennett, Lawrence ;

Kostenko, Maria ;

Landau, Michele ;

Keidar, Shlomo ;

Levy, Yishai ;

Khemlin, Alexander ;

Radan, Arman ;

Levy, Andrew P. .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (03) :E18-E20

[6]

BOWMAN BH, 1982, ADV HUM GENET, V12, P189

[7]

Haptoglobin genotype - A determinant of cardiovascular complication risk in type 1 diabetes [J].

Costacou, Tina ;

Ferrell, Robert E. ;

Orchard, Trevor J. .

DIABETES, 2008, 57 (06) :1702-1706

[8]

Identification of the haemoglobin scavenger receptor [J].

Kristiansen, M ;

Graversen, JH ;

Jacobsen, C ;

Sonne, O ;

Hoffman, HJ ;

Law, SKA ;

Moestrup, SK .

NATURE, 2001, 409 (6817) :198-201

[9]

Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype implications for the response to intraplaque hemorrhage and plaque vulnerability [J].

Levy, Andrew P. ;

Purushothaman, K. Raman ;

Levy, Nina S. ;

Purushothaman, Meerarani ;

Strauss, Merav ;

Asleh, Rabea ;

Marsh, Stuart ;

Cohen, Osher ;

Moestrup, Soren K. ;

Moller, Holger J. ;

Zias, Elias A. ;

Benhayon, Daniel ;

Fuster, Valentin ;

Moreno, Pedro R. .

CIRCULATION RESEARCH, 2007, 101 (01) :106-110

[10]

The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes [J].

Levy, AP ;

Gerstein, HC ;

Miller-Lotan, R ;

Rather, R ;

McQueen, M ;

Lonn, E ;

Pogue, J .

DIABETES CARE, 2004, 27 (11) :2767-2767

← 1 2 →